TY - JOUR AU - Brody, J. P. PY - 1995 DA - 1995// TI - Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents JO - Cancer VL - 75 UR - https://doi.org/3.0.CO;2-Y DO - 3.0.CO;2-Y ID - Brody1995 ER - TY - JOUR AU - Feuillard, J. PY - 2002 DA - 2002// TI - Clinical and biologic features of CD4(+) CD56(+) malignancies JO - Blood VL - 99 UR - https://doi.org/10.1182/blood.V99.5.1556 DO - 10.1182/blood.V99.5.1556 ID - Feuillard2002 ER - TY - JOUR AU - Facchetti, F. PY - 2009 DA - 2009// TI - Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm JO - Haematologica VL - 94 UR - https://doi.org/10.3324/haematol.13855 DO - 10.3324/haematol.13855 ID - Facchetti2009 ER - TY - JOUR AU - Garnache-Ottou, F. PY - 2009 DA - 2009// TI - Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia JO - Br J Haematol VL - 145 UR - https://doi.org/10.1111/j.1365-2141.2009.07679.x DO - 10.1111/j.1365-2141.2009.07679.x ID - Garnache-Ottou2009 ER - TY - JOUR AU - Pagano, L. PY - 2016 DA - 2016// TI - Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches JO - Br J Haematol VL - 174 UR - https://doi.org/10.1111/bjh.14146 DO - 10.1111/bjh.14146 ID - Pagano2016 ER - TY - JOUR AU - Herling, M. AU - Jones, D. PY - 2007 DA - 2007// TI - CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells JO - Am J Clin Pathol VL - 127 UR - https://doi.org/10.1309/FY6PK436NBK0RYD4 DO - 10.1309/FY6PK436NBK0RYD4 ID - Herling2007 ER - TY - JOUR AU - Frankel, A. E. PY - 2014 DA - 2014// TI - Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-04-566737 DO - 10.1182/blood-2014-04-566737 ID - Frankel2014 ER - TY - JOUR AU - Pagano, L. PY - 2013 DA - 2013// TI - Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study JO - Haematologica VL - 98 UR - https://doi.org/10.3324/haematol.2012.072645 DO - 10.3324/haematol.2012.072645 ID - Pagano2013 ER - TY - JOUR AU - Julia, F. PY - 2014 DA - 2014// TI - Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients JO - Am J Surg Pathol VL - 38 UR - https://doi.org/10.1097/PAS.0000000000000156 DO - 10.1097/PAS.0000000000000156 ID - Julia2014 ER - TY - JOUR AU - Jegalian, A. G. AU - Facchetti, F. AU - Jaffe, E. S. PY - 2009 DA - 2009// TI - Plasmacytoid Dendritic Cells Physiologic Roles and Pathologic States JO - Advances in Anatomic Pathology VL - 16 UR - https://doi.org/10.1097/PAP.0b013e3181bb6bc2 DO - 10.1097/PAP.0b013e3181bb6bc2 ID - Jegalian2009 ER - TY - JOUR AU - Jardin, F. PY - 2011 DA - 2011// TI - TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm JO - Br J Haematol VL - 153 UR - https://doi.org/10.1111/j.1365-2141.2010.08556.x DO - 10.1111/j.1365-2141.2010.08556.x ID - Jardin2011 ER - TY - JOUR AU - Dijkman, R. PY - 2007 DA - 2007// TI - Gene-expression profiling and array-based CGH classify CD4+ CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-04-018143 DO - 10.1182/blood-2006-04-018143 ID - Dijkman2007 ER - TY - JOUR AU - Pemmaraju, N. PY - 2012 DA - 2012// TI - Analysis of outcomes of patients (pts) with blastic plasmacytoid dendritic cell neoplasm (BPDCN) JO - J Clin Oncol VL - 30 ID - Pemmaraju2012 ER - TY - JOUR AU - Roos-Weil, D. PY - 2013 DA - 2013// TI - Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-08-448613 DO - 10.1182/blood-2012-08-448613 ID - Roos-Weil2013 ER - TY - JOUR AU - Benton, C. B. AU - Ravandi, F. PY - 2017 DA - 2017// TI - A mind map for managing minimal residual disease in acute myeloid leukemia JO - Clin Adv Hematol Oncol VL - 15 ID - Benton2017 ER -